REG - RUA Life Sciences - Cancellation & Reissue Share Options

Rua Life SciencesAnnouncement

Wed 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251210:nRSJ0622La&default-theme=true

RNS Number : 0622L  RUA Life Sciences PLC  10 December 2025

10 December 2025

 

RUA Life Sciences Plc

("RUA Life Sciences", the "Company" or the "Group")

Cancellation & Reissue Share Options, PDMR Notice

RUA Life Sciences (AIM: RUA), the holding company of a group of medical device
businesses focused on the exploitation of the world's leading long-term
implantable biostable polymer (Elast-Eon™), announces that it has today
cancelled, for nil consideration, certain options previously granted on 19
June 2024.

An administrative oversight following grant resulted in such options failing
to be registered for EMI.  The board have therefore agreed to rectify this
through the cancellation and re-grant, to put the employees in no worse
position than they would have been.

An equivalent number of new options have therefore been granted over ordinary
shares of 5 pence each in the Company ("Options") under the Enterprise
Management Incentive (EMI) share option scheme.  The number, exercise price
and the vesting terms and conditions of the new Options are the same as the
options cancelled.

A total of 2,900,000 EMI Options have been granted, allocated as follows:

 Name             Options cancelled (19 June 2024 Grant)  Options Granted (re-Grant)  Plan  Exercise price
 William Brown    1,400,000                               1,400,000                   EMI   11 pence
 Lachlan Smith    1,200,000                               1,200,000                   EMI   11 pence
 Other employees  300,000                                 300,000                     EMI   11 pence

 

Vesting and exercise

 

·      Options vest on 19 June 2027 (three years after original grant)
and are exercisable up to the plan long-stop (10 years from original grant).

·      In the event of an offer to acquire the whole company prior to
the plan long-stop date, vesting may accelerate in accordance with plan rules.

·      If a return of capital is proposed at an amount per share that is
greater than the exercise price per share of these options, they will vest
immediately prior to such return of capital to allow option holders to
participate.

 

Following the cancelation and issuance of these share options, the Company had
and will continue to have 5,625,603 shares under option being 9 % of the
issued share capital of the Company.

 

For further information contact:

 

   RUA Life Sciences

 Bill Brown, Chairman                                                  Tel: +44 (0)1294 317073

 Lachlan Smith, CFO                                                    Tel: +44 (0)1294 317073

 Cavendish Capital Markets                                             Tel: +44 (0)20 7220 0500
 Limited

 (Nominated Adviser and Broker)

 Giles Balleny/Isaac Hooper (Corporate Finance)

 Harriet Ward (Broking)

 Nigel Birks (Healthcare Specialist Sales)

 Michael Johnson (Sales)

 

 1                                   Details of the person discharging managerial responsibilities / person closely
                                     associated
 a)  Name

                                                                                     1.     William Brown

                                                                                     2.     Lachlan Smith
 2                                   Reason for the notification
 a)  Position/status

                                                                                     1.     Chief Executive Officer

                                                                                     2.     Chief Financial Officer

 b)  Initial notification /Amendment                                                 Initial Notification
 3                                   Details of the issuer, emission allowance market participant, auction
                                     platform, auctioneer or auction monitor
 a)  Name                                                                            Rua Life Sciences Plc
 b)  LEI                                                                             213800BMVB22PVOJ9Z28
 4                                   Details of the transaction(s): section to be repeated for (i) each type of
                                     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
                                     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument                     Options over Ordinary Shares of £0.05 each
                                     Identification code                                             ISIN
                                                                                                     :
                                                                                                     GB00
                                                                                                     3336
                                                                                                     0586
 b)  Nature of the transaction                                                       Grant and cancellation of options
 c)  Price(s) and volume(s)
                                                                                                                            Price(s)               Volume(s)
                                                                                                     1.                     £0.11 (Grant)          1,400,000
                                                                                                                            £0.11 (Cancellation)   1,400,000
                                                                                                     2.                     £0.11 (Grant)          1,200,000
                                                                                                     £0.11 (Cancellation)   1,200,000
 d)  Aggregated information
                                     - Aggregated volume                                             N/A
                                     - Price                                                         N/A
 e)  Date of the transaction                                                         10 December 2025
 f)  Place of the transaction                                                        Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFFFFLSEISEIE



            Copyright 2019 Regulatory News Service, all rights reserved